TY - JOUR A1 - Fathy, Moustafa A1 - Okabe, Motonori A1 - Othman, Eman M. A1 - Saad Eldien, Heba M. A1 - Yoshida, Toshiko T1 - Preconditioning of adipose-derived mesenchymal stem-like cells with eugenol potentiates their migration and proliferation in vitro and therapeutic abilities in rat hepatic fibrosis JF - Molecules N2 - Mesenchymal stem cells (MSCs) have considerable therapeutic abilities in various disorders, including hepatic fibrosis. They may be affected with different culture conditions. This study investigated, on molecular basics, the effect of pretreatment with eugenol on the characteristics of adipose tissue-derived MSCs (ASCs) in vitro and the implication of eugenol preconditioning on the in vivo therapeutic abilities of ASCs against CCl\(_4\)-induced hepatic fibrosis in rats. The effect of eugenol on ASCs was assessed using viability, scratch migration and sphere formation assays. Expressions of genes and proteins were estimated by immunofluorescence or qRT-PCR. For the in vivo investigations, rats were divided into four groups: the normal control group, fibrotic (CCl\(_4\)) group, CCl\(_4\)+ASCs group and CCl\(_4\) + eugenol-preconditioned ASCs (CCl\(_4\)+E-ASCs) group. Eugenol affected the viability of ASCs in a concentration- and time-dependent manner. Eugenol improved their self-renewal, proliferation and migration abilities and significantly increased their expression of c-Met, reduced expression 1 (Rex1), octamer-binding transcription factor 4 (Oct4) and nanog genes. Furthermore, E-ASCs showed more of a homing ability than ASCs and improved the serum levels of ALT, AST, albumin, total bilirubin and hyaluronic acid more efficient than ASCs in treating CCl\(_4\)-induced hepatic fibrosis, which was confirmed with histopathology. More interestingly, compared to the CCl\(_4\)+ASCs group, CCl\(_4\)+E-ASCs group showed a lower expression of inducible nitric oxide synthase (iNOS), monocyte chemoattractant protein-1 (MCP-1), cluster of differentiation 163 (CD163) and tumor necrosis factor-α (TNF-α) genes and higher expression of matrix metalloproteinase (MMP)-9 and MMP-13 genes. This study, for the first time, revealed that eugenol significantly improved the self-renewal, migration and proliferation characteristics of ASCs, in vitro. In addition, we demonstrated that eugenol-preconditioning significantly enhanced the therapeutic abilities of the injected ASCs against CCl\(_4\)-induced hepatic fibrosis. KW - adipose tissue-derived MSCs KW - eugenol KW - migration KW - self-renewal KW - hepatic fibrosis KW - CCl\(_4\) Y1 - 2020 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-203662 SN - 1420-3049 VL - 25 IS - 9 ER - TY - JOUR A1 - Scognamiglio, Roberta A1 - Cabezas-Wallscheid, Nina A1 - Thier, Marc Christian A1 - Altamura, Sandro A1 - Reyes, Alejandro A1 - Prendergast, Áine M. A1 - Baumgärtner, Daniel A1 - Carnevalli, Larissa S. A1 - Atzberger, Ann A1 - Haas, Simon A1 - von Paleske, Lisa A1 - Boroviak, Thorsten A1 - Wörsdörfer, Philipp A1 - Essers, Marieke A. G. A1 - Kloz, Ulrich A1 - Eisenman, Robert N. A1 - Edenhofer, Frank A1 - Bertone, Paul A1 - Huber, Wolfgang A1 - van der Hoeven, Franciscus A1 - Smith, Austin A1 - Trumpp, Andreas T1 - Myc depletion induces a pluripotent dormant state mimicking diapause JF - Cell N2 - Mouse embryonic stem cells (ESCs) are maintained in a naive ground state of pluripotency in the presence of MEK and GSK3 inhibitors. Here, we show that ground-state ESCs express low Myc levels. Deletion of both c-myc and N-myc (dKO) or pharmacological inhibition of Myc activity strongly decreases transcription, splicing, and protein synthesis, leading to proliferation arrest. This process is reversible and occurs without affecting pluripotency, suggesting that Myc-depleted stem cells enter a state of dormancy similar to embryonic diapause. Indeed, c-Myc is depleted in diapaused blastocysts, and the differential expression signatures of dKO ESCs and diapaused epiblasts are remarkably similar. Following Myc inhibition, pre-implantation blastocysts enter biosynthetic dormancy but can progress through their normal developmental program after transfer into pseudo-pregnant recipients. Our study shows that Myc controls the biosynthetic machinery of stem cells without affecting their potency, thus regulating their entry and exit from the dormant state. KW - hematopoietic stem cells KW - leukemia inhibitory factor KW - c-Myc KW - N-Myc KW - gene expression KW - embryonic stem cells KW - self-renewal KW - protein synthesis Y1 - 2016 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-190868 VL - 164 IS - 4 ER -